An algorithmic approach to structural imaging in dementia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 6, 2014, Pages 692-698

  Harper, Lorna ^a   Barkhof, Frederik ^b   Scheltens, Philip ^b   Schott, Jonathan M ^a   Fox, Nick C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BRAIN ATROPHY; BRAIN INFARCTION; CORPUS STRIATUM; FLUID ATTENUATED INVERSION RECOVERY; FOCAL HIPPOCAMPAL ATROPHY; FOCAL LOBAR ATROPHY; FRONTAL LOBE; HUMAN; INFRATENTORIAL ATROPHY; MULTIINFARCT DEMENTIA; NEOCORTEX; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE; WHITE MATTER;

DEMENTIA; IMAGE ANALYSIS; MRI; NEURORADIOLOGY; VASCULAR DEMENTIA;

AGED; AGED, 80 AND OVER; ALGORITHMS; ALZHEIMER DISEASE; ATROPHY; BRAIN; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; EUROPE; FEMALE; GREAT BRITAIN; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROIMAGING; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; SUPRANUCLEAR PALSY, PROGRESSIVE; UNITED STATES;

EID: 84899983558     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-306285     Document Type: Review

References (73)

1. World Health Organisation. Alzheimer's disease international. Dementia: A public health priority. WHO Press, 2012.
2. Direction générale de l'action sociale, Direction de la sécurité sociale, Direction de l'hospitalisation et de l'organisation des soins. Plan Alzheimer et maladies apparentées 2008-2012. 2008.
3. UK Department of Health. Living well with dementia: a National Dementia Strategy. 2009.
4. UK Department of Health. Prime minister's challenge on dementia- Delivering major improvements in dementia care and research by 2015. 2012.
5. US Department of Health and Human Services. National plan to address Alzheimer's disease. 2012.
6. de Vries K, Brooker DJ, Smith P. Dementia skills and competencies for primary care liaison: a model for improving identification and timely diagnosis. Prim Health Care Res Dev 2013 Jul;14(3):240-9.
7. Joray S, Wietlisbach V, Büla CJ. Cognitive impairment in elderly medical inpatients: detection and associated six-month outcomes. Am J Geriatr Psychiatry 2004;12:639-47. (Pubitemid 41031066)
8. Mitchell AJ, Meader N, Pentzek M. Clinical recognition of dementia and cognitive impairment in primary care: a meta-analysis of physician accuracy. Acta Psychiatr Scand 2011;124:165-83.
9. Sampson EL, Blanchard MR, Jones L, et al. Dementia in the acute hospital: prospective cohort study of prevalence and mortality. Br J Psychiatry 2009;195:61-6.
10. Cohn-Hokke PE, Elting MW, Pijnenburg YAL, et al. Genetics of dementia: update and guidelines for the clinician. Am J Med Genet B Neuropsychiatr Genet. 2012;159B:628-43.
11. Rossor MN, Fox NC, Mummery CJ, et al. The diagnosis of young-onset dementia. Lancet Neurol 2010;9:793-806.
12. Clark CM, Pontecorvo MJ, Beach TG, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-βplaques: a prospective cohort study. Lancet Neurol 2012;11:669-78.
13. Mattsson N, Zetterberg H, Hansson O, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 2009;302:385-93.
14. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-46. (Pubitemid 47058377)
15. Hort J, O'Brien JT, Gainotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol 2010;17:1236-48.
16. Jack CR Jr, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:257-62.
17. NCC for Mental Health. Dementia: The NICE-SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care (National Clinical Practice Guideline). British Psychological Society and RCPsych Publications; 2007.
18. Scheltens P, Fox N, Barkhof F, et al. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol 2002;1:13-21. (Pubitemid 37159194)
19. Barkof F, Fox NC, Bastos-Leite AJ, et al. Neuroimaging in Dementia. Springer Berlin Heidelberg, 2011.
20. Likeman M, Anderson VM, Stevens JM, et al. Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. Arch Neurol 2005;62:1410-15. (Pubitemid 41352058)
21. Di Ieva A, Valli M, Cusimano MD. Distinguishing Alzheimer's disease from normal pressure hydrocephalus: a search for MRI biomarkers. J Alzheimers Dis 2013. [Epub ahead of print]
22. Malm J, Graff-Radford NR, Ishikawa M, et al. Influence of comorbidities in idiopathic normal pressure hydrocephalus -research and clinical care. A report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS 2013;10:22.
23. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 2011;42:2672-713.
24. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60. (Pubitemid 23060253)
25. Inzitari D, Simoni M, Pracucci G, et al. Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med 2007;167:81-8. (Pubitemid 46072411)
26. Gill DP, Hubbard RA, Koepsell TD, et al. Differences in rate of functional decline across three dementia types. Alzheimers Dement 2013 May 2. pii: S1552-5260(12)02572-1
27. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822-38.
28. Wahlund LO, Barkhof F, Fazekas F, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318-22. (Pubitemid 32530416)
29. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-6. (Pubitemid 17104996)
30. van Straaten ECW, Scheltens P, Knol DL, et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study. Stroke 2003;34:1907-12. (Pubitemid 36944779)
31. Federico A, Di Donato I, Bianchi S, et al. Hereditary cerebral small vessel diseases: a review. J Neurol Sci 2012;322:25-30.
32. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120(Pt 11):2059-69. (Pubitemid 27493740)
33. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
34. Marjo Van Der Valk JV. Magnetic resonance of myelination and myelin disorders. illustrated edn. Springer, 2005.
35. Levine AJ, Hinkin CH, Ando K, et al. An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults. J Clin Exp Neuropsychol 2008;30:836-43.
36. Carrera E, Bogousslavsky J. The thalamus and behavior: effects of anatomically distinct strokes. Neurology 2006;66:1817-23. (Pubitemid 44049809)
37. Bastos Leite AJ, van Straaten ECW, Scheltens P, et al. Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging. Stroke 2004;35:415-19. (Pubitemid 38174422)
38. Kallenberg K, Schulz-Schaeffer WJ, Jastrow U, et al. Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences. AJNR Am J Neuroradiol 2006;27:1459-62. (Pubitemid 44260128)
39. Charidimou A, Jäger HR, Werring DJ. Cerebral microbleed detection and mapping: principles, methodological aspects and rationale in vascular dementia. Exp Gerontol 2012;47:843-52.
40. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999;20:637-42. (Pubitemid 30429021)
41. Cordonnier C, van der Flier WM. Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain 2011;134(Pt 2):335-44.
42. Ryan NS, Bastos-Leite AJ, Rohrer JD, et al. Cerebral microbleeds in familial Alzheimer's disease. Brain 2012;135(Pt 1):e201; author reply e202.
43. Poels MMF, Ikram MA, van der Lugt A, et al. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke 2011;42:656-61.
44. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology 2011;76:1006-14.
45. Lindberg O, Ostberg P, Zandbelt BB, et al. Cortical morphometric subclassification of frontotemporal lobar degeneration. AJNR Am J Neuroradiol 2009;30:1233-9.
46. Whitwell JL, Xu J, Mandrekar J, et al. Frontal asymmetry in behavioral variant frontotemporal dementia: clinicoimaging and pathogenetic correlates. Neurobiol Aging 2013;34:636-9.
47. Lee SE, Rabinovici GD, Mayo MC, et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol 2011;70:327-40.
48. Rohrer JD, Lashley T, Schott JM, et al. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 2011;134(Pt 9):2565-81.
49. Whitwell JL, Josephs KA. Neuroimaging in frontotemporal lobar degeneration-predicting molecular pathology. Nat Rev Neurol 2011;8:131-42.
50. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53:795-800. (Pubitemid 29448302)
51. Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013;80:496-503.
52. Rohrer JD, Clarkson MJ, Kittus R, et al. Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degeneration. J Alzheimers Dis 2012;30:407-11.
53. Chan D, Fox NC, Scahill RI, et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer' s disease. Ann Neurol 2001;49:433-42. (Pubitemid 32281327)
54. Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004;55:335-46. (Pubitemid 38269585)
55. Chan D, Anderson V, Pijnenburg Y, et al. The clinical profile of right temporal lobe atrophy. Brain 2009;132(Pt 5):1287-98.
56. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134(Pt 9):2456-77.
57. Rosen HJ, Allison SC, Schauer GF, et al. Neuroanatomical correlates of behavioural disorders in dementia. Brain 2005;128(Pt 11):2612-25. (Pubitemid 41552946)
58. Rohrer JD, Ridgway GR, Crutch SJ, et al. Progressive logopenic/ phonological aphasia: erosion of the language network. Neuroimage 2010;49:984-93.
59. Lehmann M, Koedam ELGE, Barnes J, et al. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiol Aging 2012;33:627.e1-627.e12.
60. Koedam ELGE, Lehmann M, van der Flier WM, et al. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol 2011;21:2618-25.
61. Beck J, Rohrer JD, Campbell T, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 2008;1313):706-20.
62. Rohrer JD, Ridgway GR, Modat M, et al. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage 2010;53:1070-6.
63. Whitwell JL, Weigand SD, Boeve BF, et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain 2012;135(Pt 3):794-806.
64. Westman E, Cavallin L, Muehlboeck JS, et al. Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS One 2011;6:e22506.
65. Burton EJ, Barber R, Mukaetova-Ladinska EB, et al. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 2009;132(Pt 1):195-203.
66. McKeith IG, Dickson DW, Lowe J, et al . Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-72. (Pubitemid 43970103)
67. Ince P, Irving D, MacArthur F, et al. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. J Neurol Sci 1991;106:142-52.
68. Walker Z, Jaros E, Walker RWH, et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry 2007;78:1176-81. (Pubitemid 350057277)
69. Rohrer JD, Warren JD. Phenotypic signatures of genetic frontotemporal dementia. Curr Opin Neurol 2011;24:542-9.
70. Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;54:697-702. (Pubitemid 30082941)
71. Hampel H, Bürger K, Teipel SJ, et al. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement 2008;4:38-48.
72. Hampel H, Frank R, Broich K, et al. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 2010;9:560-74.
73. Giorgio A, De Stefano N. Clinical use of brain volumetry. J Magn Reson Imaging 2013;37:1-14.